» Articles » PMID: 32561688

New Insights into the Pathophysiological Mechanisms Underlying Cardiorenal Syndrome

Overview
Specialty Geriatrics
Date 2020 Jun 21
PMID 32561688
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Communication between the heart and kidney occurs through various bidirectional pathways. The heart maintains continuous blood flow through the kidney while the kidney regulates blood volume thereby allowing the heart to pump effectively. Cardiorenal syndrome (CRS) is a pathologic condition in which acute or chronic dysfunction of the heart or kidney induces acute or chronic dysfunction of the other organ. CRS type 3 (CRS-3) is defined as acute kidney injury (AKI)-mediated cardiac dysfunction. AKI is common among critically ill patients and correlates with increased mortality and morbidity. Acute cardiac dysfunction has been observed in over 50% of patients with severe AKI and results in poorer clinical outcomes than heart or renal dysfunction alone. In this review, we describe the pathophysiological mechanisms responsible for AKI-induced cardiac dysfunction. Additionally, we discuss current approaches in the management of patients with CRS-3 and the development of targeted therapeutics. Finally, we summarize current challenges in diagnosing mild cardiac dysfunction following AKI and in understanding CRS-3 etiology.

Citing Articles

Thromboinflammatory Biomarkers of Cardiorenal Syndrome in Patients With End-Stage Renal Disease.

Karumanchi P, Sridharan D, Hoppensteadt D, Siddiqui F, Fareed J, Bansal V Clin Appl Thromb Hemost. 2024; 30:10760296241263101.

PMID: 38863224 PMC: 11179552. DOI: 10.1177/10760296241263101.


Dual-specificity phosphatase 1 interacts with prohibitin 2 to improve mitochondrial quality control against type-3 cardiorenal syndrome.

Liu N, Ding Y, Zhou H, Chang X, Lou L Int J Med Sci. 2024; 21(3):547-561.

PMID: 38322592 PMC: 10845262. DOI: 10.7150/ijms.90484.


New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy.

Gallo G, Lanza O, Savoia C Int J Mol Sci. 2023; 24(6).

PMID: 36982164 PMC: 10049666. DOI: 10.3390/ijms24065089.


Could Repeated Cardio-Renal Injury Trigger Late Cardiovascular Sequelae in Extreme Endurance Athletes?.

Burtscher J, Vanderriele P, Legrand M, Predel H, Niebauer J, OKeefe J Sports Med. 2022; 52(12):2821-2836.

PMID: 35851948 PMC: 9691495. DOI: 10.1007/s40279-022-01734-8.


Beyond the Cardiorenal Syndrome: Pathophysiological Approaches and Biomarkers for Renal and Cardiac Crosstalk.

Buliga-Finis O, Ouatu A, Badescu M, Dima N, Tanase D, Richter P Diagnostics (Basel). 2022; 12(4).

PMID: 35453821 PMC: 9028970. DOI: 10.3390/diagnostics12040773.


References
1.
Zhou H, Toan S . Pathological Roles of Mitochondrial Oxidative Stress and Mitochondrial Dynamics in Cardiac Microvascular Ischemia/Reperfusion Injury. Biomolecules. 2020; 10(1). PMC: 7023463. DOI: 10.3390/biom10010085. View

2.
Bongartz L, Cramer M, Doevendans P, Joles J, Braam B . The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J. 2004; 26(1):11-7. DOI: 10.1093/eurheartj/ehi020. View

3.
Wang J, Yu W, Zhou Y, Yang Y, Li C, Liu N . Independent Risk Factors Contributing to Acute Kidney Injury According to Updated Valve Academic Research Consortium-2 Criteria After Transcatheter Aortic Valve Implantation: A Meta-analysis and Meta-regression of 13 Studies. J Cardiothorac Vasc Anesth. 2017; 31(3):816-826. DOI: 10.1053/j.jvca.2016.12.021. View

4.
Wu V, Wu C, Huang T, Wang C, Lai C, Shiao C . Long-term risk of coronary events after AKI. J Am Soc Nephrol. 2014; 25(3):595-605. PMC: 3935592. DOI: 10.1681/ASN.2013060610. View

5.
Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs L . Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol. 1997; 29(3):859-70. DOI: 10.1006/jmcc.1996.0333. View